Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Human MUC1 mucin: a multifaceted glycoprotein.
von Mensdorff-Pouilly S, Snijdewint FG, Verstraeten AA, Verheijen RH, Kenemans P. von Mensdorff-Pouilly S, et al. Int J Biol Markers. 2000 Oct-Dec;15(4):343-56. Int J Biol Markers. 2000. PMID: 11192832 Review.
What makes MUC1 a tumor antigen?
Karsten U, von Mensdorff-Pouilly S, Goletz S. Karsten U, et al. Tumour Biol. 2005 Jul-Aug;26(4):217-20. doi: 10.1159/000086956. Epub 2005 Jul 6. Tumour Biol. 2005. PMID: 16006776 Review.
Cancer specific Mucin-1 glycoforms are expressed on multiple myeloma.
Cloosen S, Gratama J, van Leeuwen EB, Senden-Gijsbers BL, Oving EB, von Mensdorff-Pouilly S, Tarp MA, Mandel U, Clausen H, Germeraad WT, Bos GM. Cloosen S, et al. Br J Haematol. 2006 Nov;135(4):513-6. doi: 10.1111/j.1365-2141.2006.06331.x. Epub 2006 Sep 28. Br J Haematol. 2006. PMID: 17010104
Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer.
Oei AL, Moreno M, Verheijen RH, Sweep FC, Thomas CM, Massuger LF, von Mensdorff-Pouilly S. Oei AL, et al. Int J Cancer. 2008 Oct 15;123(8):1848-53. doi: 10.1002/ijc.23725. Int J Cancer. 2008. PMID: 18661524 Clinical Trial.
IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
Moreno M, Molling JW, von Mensdorff-Pouilly S, Verheijen RH, Hooijberg E, Kramer D, Reurs AW, van den Eertwegh AJ, von Blomberg BM, Scheper RJ, Bontkes HJ. Moreno M, et al. Among authors: von mensdorff pouilly s. J Immunol. 2008 Aug 15;181(4):2446-54. doi: 10.4049/jimmunol.181.4.2446. J Immunol. 2008. PMID: 18684935 Free article.
Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC).
Moreno M, Mol BM, von Mensdorff-Pouilly S, Verheijen RH, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Bontkes HJ. Moreno M, et al. Cancer Lett. 2008 Dec 8;272(1):70-6. doi: 10.1016/j.canlet.2008.06.028. Epub 2008 Aug 5. Cancer Lett. 2008. PMID: 18684557
Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses.
von Mensdorff-Pouilly S, Kinarsky L, Engelmann K, Baldus SE, Verheijen RH, Hollingsworth MA, Pisarev V, Sherman S, Hanisch FG. von Mensdorff-Pouilly S, et al. Glycobiology. 2005 Aug;15(8):735-46. doi: 10.1093/glycob/cwi058. Epub 2005 Apr 6. Glycobiology. 2005. PMID: 15814824
Cellular and humoral responses after multiple injections of unconjugated chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot study.
van Zanten-Przybysz I, Molthoff C, Gebbinck JK, von Mensdorff-Pouilly S, Verstraeten R, Kenemans P, Verheijen R. van Zanten-Przybysz I, et al. J Cancer Res Clin Oncol. 2002 Sep;128(9):484-92. doi: 10.1007/s00432-002-0348-z. Epub 2002 Aug 23. J Cancer Res Clin Oncol. 2002. PMID: 12242512 Clinical Trial.
A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
Davelaar EM, van de Lande J, von Mensdorff-Pouilly S, Blankenstein MA, Verheijen RH, Kenemans P. Davelaar EM, et al. Tumour Biol. 2008;29(1):9-17. doi: 10.1159/000132566. Epub 2008 May 23. Tumour Biol. 2008. PMID: 18497544
High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC).
Moreno M, Bontkes HJ, Scheper RJ, Kenemans P, Verheijen RH, von Mensdorff-Pouilly S. Moreno M, et al. Cancer Lett. 2007 Nov 8;257(1):47-55. doi: 10.1016/j.canlet.2007.06.016. Epub 2007 Aug 9. Cancer Lett. 2007. PMID: 17692456
55 results
Jump to page